St. Louis-based PierianDx, which provides a genomics SaaS platform for clinical labs to build personalized medicine programs, raises $27M Series B (Alaric DeArment/MedCity News)
St. Louis-based PierianDx, which provides a genomics SaaS platform for clinical labs to build personalized medicine programs, raises $27M Series B — The startup describes its software as providing clinical labs with more streamlined and accurate analysis, interpretation and reporting for accelerating personalized medicine programs.
from Techmeme https://ift.tt/36x7KRM
St. Louis-based PierianDx, which provides a genomics SaaS platform for clinical labs to build personalized medicine programs, raises $27M Series B (Alaric DeArment/MedCity News)
![St. Louis-based PierianDx, which provides a genomics SaaS platform for clinical labs to build personalized medicine programs, raises $27M Series B (Alaric DeArment/MedCity News)]()
Reviewed by swadu
on
November 02, 2019
Rating:
No comments: